Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 46

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

468	$NVLX Nuvilex Accelerates Development of	stocklegend	02/19/2014 3:55:19 PM
467	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/19/2014 1:59:33 PM
466	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/19/2014 1:28:09 PM
465	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/19/2014 12:06:10 PM
464	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/19/2014 11:41:44 AM
463	NVLX news"	stocklegend	02/19/2014 11:20:52 AM
462	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/19/2014 11:20:32 AM
461	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/19/2014 8:57:18 AM
460	Nuvilex is a biotechnology company with the	Tandrel	02/19/2014 8:44:50 AM
459	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/18/2014 3:32:41 PM
458	$NVLX Nuvilex Accelerates Development of	stocklegend	02/18/2014 2:59:30 PM
457	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/18/2014 2:24:18 PM
456	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/18/2014 1:32:50 PM
455	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/18/2014 12:37:45 PM
454	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/18/2014 12:00:50 PM
453	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/18/2014 9:57:19 AM
452	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/18/2014 9:27:33 AM
451	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/18/2014 9:08:29 AM
450	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/18/2014 8:49:57 AM
449	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/14/2014 2:11:37 PM
448	$NVLX Nuvilex Accelerates Development of	stocklegend	02/14/2014 1:58:16 PM
447	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/14/2014 1:14:33 PM
446	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/14/2014 12:07:50 PM
445	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/14/2014 11:52:37 AM
444	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/14/2014 11:35:15 AM
443	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/14/2014 10:23:48 AM
442	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/14/2014 10:03:31 AM
441	Nuvilex has received plenty of hype over their	Tandrel	02/14/2014 9:22:14 AM
440	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/14/2014 9:19:43 AM
439	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/14/2014 8:51:35 AM
438	$NVLX Nuvilex COO Talks About Companys	stocklegend	02/13/2014 3:54:44 PM
437	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	02/13/2014 3:33:31 PM
436	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/13/2014 1:01:48 PM
435	$NVLX - Nuvilex COO Talks Medical Marijuana in	stocklegend	02/13/2014 12:30:55 PM
434	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/13/2014 11:35:29 AM
433	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/13/2014 11:18:47 AM
432	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/13/2014 9:58:15 AM
431	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/13/2014 9:51:41 AM
430	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/13/2014 9:04:45 AM
429	Nuvilex, Inc. ($NVLX) shares closed up 6.87	Tandrel	02/13/2014 8:57:38 AM
428	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/13/2014 8:49:51 AM
427	$NVLX Nuvilex COO Talks About Companys	stocklegend	02/12/2014 2:16:34 PM
426	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/12/2014 1:50:35 PM
425	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	02/12/2014 1:17:20 PM
424	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	02/12/2014 12:37:21 PM
423	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/12/2014 12:23:38 PM
422	The live-cell encapsulation technology employed	jschrager23	02/12/2014 11:46:36 AM
421	NEW YORK, NY--(Marketwired - Feb 12, 2014) -	jschrager23	02/12/2014 11:46:01 AM
420	HUGE NEWS OUT TODAY!	jschrager23	02/12/2014 11:45:38 AM
419	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/12/2014 11:16:30 AM

Newer

Older

Recent Articles

• Exploring Cultural Exchange Through 'Liangzhu' Documentary
• EDF Secures €6 Billion Credit Facility to Boost ESG Commitments
• Journey Through China's Ethnic Treasures: A Cultural Odyssey
• Transforming Waste into Sustainable Energy: Innovations Ahead
• Investors Urged to Join Class Action Against Chipotle
• Vantage Drilling Secures $50 Million in Senior Secured Notes
• Primega Group Holdings Resolves Nasdaq Compliance Issues
• Exploring Culinary Delights at the China Supply Chain Show
• High Arctic Overseas Reports Q3 2024 Financial Highlights
• Grab Unmissable Offers Before Monport's Black Friday Ends
• Canadian Spirit Resources Highlights First Quarter Financials
• Innovation at the Expo: Where Sci-Fi Meets Reality
• Rakovina Therapeutics Reports Q3 Financial Progress and Innovations
• Innovative Transportation Concepts at the China Supply Chain Expo
• Exploring Hotpot Culture at the China International Supply Chain Expo
• CBC Group and Mubadala Form NeuroGen Pharma for Growth
• GVD Markets Launches Global Expansion with Unique Trading Solutions
• CBC Group and Mubadala Form NeuroGen Pharma in China Deal
• Hampton Financial Corporation Distributes Stock Options for Growth
• Tice Family Takes Stand for Journalist in Press Conference
• ProMortgage Expands Team With Four Experienced Professionals
• Unlock Seamless Communication with iFLYTEK's Smart Translator
• Investor Alert: Acadia Healthcare Class Action Insights
• O2Gold Expands Acquisition Plans for Quebec Aur Property
• Brazil Potash Celebrates Successful Initial Public Offering
• ISS Endorses Director Nominees for Carver Bancorp, Inc.
• Deadline for Shareholder Distribution Approval Announced by LWP
• Axis Auto Finance Inc. Annual Meeting Voting Results Overview
• Fluent, Inc. Secures $5.75 Million Through Direct Offerings
• The Future of Silicon Photonics: Trends and Insights for Growth
• Expansion of Managed Services Market in Saudi Arabia Forecasted
• Cloud ERP Market Growth Driven by AI and Digital Transformation
• Exploring the Growth of the Titanium Market and AI's Impact
• Syntheia: Transforming Customer Engagement with AI Solutions
• Photonics Market Growth Forecast: Major Innovations Ahead
• Strategic Management Transition at Premier American Uranium
• Financial Overview of Patagonia Gold for Q3 2024
• First Savings Financial Group Declares Quarterly Dividend for 2024
• Anoto Group Introduces Its Latest Prospectus for Investment Opportunities
• Inovalis REIT Moves Forward with €18.2 Million Property Sale
• State Street Leadership Prepares for Goldman Sachs Conference
• XTM Inc. Celebrates Impressive Q3 2024 Performance with Growth
• Investors Excited for Lightspeed's Upcoming Conference Participation
• Emerging Trends in Cannabis Testing Market Boost Growth
• Halmont Properties' Strong Q3 Performance and Future Outlook
• Brookfield Infrastructure Announces Major Subordinated Note Deal
• Investigation Launched Against Customers Bancorp, Inc. Amid Losses
• Red White & Bloom Achieves Major Growth in Q3 Financials
• Cue Biopharma Welcomes New Chief Development Officer
• WeRide Inc. Launches GXR Robotaxi Platform and Strategic Growth